Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haifeng Pan
Observed name:
H. Pan
Institutions:
Xiamen University,
National Medical Products Administration
Observed institutions:
Xiamen University,
Chinese Academy of Medical Sciences & Peking Union Medical College,
National Medical Products Administration,
University of Chicago,
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics
ORCID:
0009-0005-7510-8571
Observed ORCID:
0009-0005-7510-8571
OpenAlex ID:
A5081995942
Redox-Responsive Peptide Coacervates for Enhanced mRNA Delivery and Intracellular Release
2025
·
Shuling Ren
, Xinyu Lin
, et al.
·
ACS Nano
·
7
Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
·
Cancer Immunology Research
·
5
FLASH
2006
·
K.B. Antypas
, A.C. Calder
, et al.
·
Elsevier eBooks
·
3
Supplementary Fig. S15 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S14 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S6 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Data from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S5 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S23 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S3 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S20 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S24 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Table S1 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Methods File 1 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Data from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S2 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S21 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S8 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S22 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S7 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S9 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S4 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S19 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S18 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Supplementary Fig. S17 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024
·
Haifeng Pan
, Siyuan Yu
, et al.
Show more works
View as search
Works count:
57
Citation count:
15
H-index:
3
I10-index:
Year
Topic
Type
